Available licensing opportunities:

  • Zero-concentrate evaporator technology

Executive summary
PharmaLundensis has developed a simple and cheap method which allows the evaporation process to continue until the concentrate is 100 % dry and solid, which is financially advantageous for the users. The method is patented in many countries around the world. Companies are offered to licence this proprietary technology which allows them to sell zero-concentrate evaporator systems.

Patent protection
The key aspect that is protected in our patent is the method to perform the final water reduction in the waste container, which is subsequently sent for destruction.

PharmaLundensis patent has been granted in USA and in 11 countries in the EU (Germany, France, UK, Italy, Spain, Switzerland, Netherlands, Sweden, Denmark, Norway and Finland.

In addition, patent is pending in Canada, Australia, India, China and Japan.

Licensing opportunity
PharmaLundensis offers evaporator companies to sign a non-exclusive license, which allows them to manufacture and sell evaporator systems fitted with PharmaLundensis proprietary zero-concentrate technology.

Please contact CEO Dr Staffan Skogvall for inquiries regarding licensing in specific countries: